Carlota Costa

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations

Medicine, Cancer Biology, Oncology +16

FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR

Trever G. Bivona, Haley Hieronymus, Joel S. Parker et al. · Nature · 2011 · 391 citations

Medicine, Molecular Biology, Oncology +16

Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non–Small-Cell Lung Cancer Patients with EGFR Mutations

Rafael Rosell, Miguel Angel Molina, Carlota Costa et al. · Clinical Cancer Research · 2011 · 300 citations · Full text

Medicine, Molecular Biology, Oncology +17

The Impact of <i>EGFR</i> T790M Mutations and <i>BIM</i> mRNA Expression on Outcome in Patients with <i>EGFR</i> -Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

Carlota Costa, Miguel Angel Molina, Ana Drozdowskyj et al. · Clinical Cancer Research · 2014 · 228 citations · Full text

Medicine, Oncology, Pharmacology +15

Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling

Rina Kanda, Akihiko Kawahara, Kosuke Watari et al. · Cancer Research · 2013 · 166 citations

Medicine, Oncology, Pharmacology +17